Fig. 1From: Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocationDistribution of risk groups according to the five-tiered Cambridge Prognostic Group (CPG) and the three-tiered National Prostate Cancer Audit (NPCA)/NICE stratification systemBack to article page